Yes, tizanidine is a muscle relaxer. It belongs to a class of medications called skeletal muscle relaxants and works by slowing activity in the brain and nervous system, which reduces the signals that cause muscles to tighten. It’s primarily prescribed for spasticity, the persistent muscle stiffness and spasms that can accompany conditions like multiple sclerosis, spinal cord injuries, and certain neurological disorders.
How Tizanidine Works
Unlike pain medications that simply mask discomfort, tizanidine targets the nerve signals responsible for excessive muscle tone. It acts on receptors in the spinal cord that regulate how strongly muscles contract, dialing down the overactive signals that cause stiffness and involuntary spasms. This makes it particularly useful for spasticity rather than the typical muscle soreness you might get from exercise or a pulled muscle.
Tizanidine is a short-acting medication. Its effects wear off relatively quickly, which is why it’s typically taken on an as-needed basis before activities where spasticity would be most problematic, rather than around the clock.
Common Side Effects
Tizanidine’s side effects are significant and dose-dependent. In a clinical study of patients with spasticity from multiple sclerosis, drowsiness was the most common complaint, affecting 78% of people at the lower dose and 92% at the higher dose. Dry mouth was nearly as frequent, reported by 76% and 88% of patients at those same doses. Both of these occurred at much higher rates than with a placebo.
Low blood pressure is another notable concern, showing up in 16% of patients at the lower dose and 33% at the higher dose, compared to 0% with placebo. A slowed heart rate followed a similar pattern. Because of the drowsiness and blood pressure effects, many people find it best to take tizanidine at bedtime or during times when they don’t need to be alert.
How Food and Formulation Affect Absorption
Tizanidine comes in both tablet and capsule forms, and while they’re considered equivalent when taken on an empty stomach, they don’t behave the same way with food. Capsules absorb more slowly than tablets, with a slight delay in when the drug starts working. When you take capsules with food, that delay increases further, roughly doubling the time before the drug enters your bloodstream, and the peak concentration drops by about 20%.
This matters practically because switching between tablets and capsules, or changing whether you take them with or without food, can alter how much of the drug your body absorbs at once. The key is consistency: pick one form and one routine, and stick with it.
Dangerous Drug Interactions
Tizanidine has some of the most dramatic drug interactions of any commonly prescribed muscle relaxer. The antibiotic ciprofloxacin, often prescribed for urinary tract or respiratory infections, increases tizanidine blood levels by 7 to 10 times the normal amount. The antidepressant fluvoxamine is even worse, boosting peak levels 12-fold and overall exposure 33-fold. At those concentrations, the side effects (extreme drowsiness, dangerously low blood pressure) become severe.
Both of these drugs are contraindicated with tizanidine, meaning they should never be taken together. Other medications that use the same liver pathway can cause similar problems, so any time a new prescription is added, your pharmacist or prescriber needs to check for conflicts.
Liver Monitoring
Tizanidine can affect liver function, and the FDA labeling recommends blood tests to check liver enzyme levels before starting the medication and again one month after reaching the target dose. Additional testing is recommended if signs of liver problems develop, such as unexplained nausea, fatigue, or dark urine.
Off-Label Uses
While tizanidine is officially approved for spasticity, prescribers sometimes use it for other conditions involving muscle tension or pain. It has been studied in neuropathic pain (nerve-related pain), chronic headaches, and fibromyalgia. In an open-label study of neuropathic pain, common side effects matched what’s seen in spasticity treatment: dizziness in 52% of participants, drowsiness in 48%, fatigue in 43%, and dry mouth in 39%. These off-label uses are less well established than its primary indication, and the sedation can be a limiting factor for daytime use.